学术探索
学术期刊
新闻热点
数据分析
智能评审

Does 2-methoxyestradiol represent the new and improved hormone replacement therapy for atherosclerosis?

被引：11
作者：
Dantas, Ana Paula V. [1 ]
Sandberg, Kathryn [1 ]
机构：
[1] Georgetown Univ, Ctr Study Sex Differences Hlth Aging & Dis, Washington, DC 20057 USA
来源：
CIRCULATION RESEARCH | 2006年 / 99卷 / 03期
关键词：
D O I：
10.1161/01.RES.0000236802.00855.cd
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：234 / 237
页数：4
相关论文
共 30 条
  • [1] Methoxyestradiols mediate estradiol-induced antimitogenesis in human aortic SMCs
    Barchiesi, F
    Jackson, EK
    Gillespie, DG
    Zacharia, LC
    Fingerle, J
    Dubey, RK
    [J]. HYPERTENSION, 2002, 39 (04) : 874 - 879
  • [2] 2-methoxyestradiol, an estradiol metabolite, inhibits neointima formation and smooth muscle cell growth via double blockade of the cell cycle
    Barchiesi, Federica
    Jackson, Edwin K.
    Fingerle, Juergen
    Gillespie, Delbert G.
    Odermatt, Bernhard
    Dubey, Raghvendra K.
    [J]. CIRCULATION RESEARCH, 2006, 99 (03) : 266 - 274
  • [3] Bi-directional actions of estrogen on the renin-angiotensin system
    Brosnihan, KB
    Senanayake, PS
    Li, P
    Ferrario, CM
    [J]. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 1999, 32 (04) : 373 - 381
  • [4] Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension
    Brunner, H
    Cockcroft, JR
    Deanfield, J
    Donald, A
    Ferrannini, E
    Halcox, J
    Kiowski, W
    Luscher, TF
    Mancia, G
    Natali, A
    Oliver, JJ
    Pessina, AC
    Rizzoni, D
    Rossi, GP
    Salvetti, A
    Spieker, LE
    Taddei, S
    Webb, DJ
    [J]. JOURNAL OF HYPERTENSION, 2005, 23 (02) : 233 - 246
  • [5] Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome
    Christian, RC
    Dumesic, DA
    Behrenbeck, T
    Oberg, AL
    Sheedy, PF
    Fitzpatrick, LA
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (06) : 2562 - 2568
  • [6] Estrogen status correlates with the calcium content of coronary atherosclerotic plaques in women
    Christian, RC
    Harrington, S
    Edwards, WD
    Oberg, AL
    Fitzpatrick, LA
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (03) : 1062 - 1067
  • [7] Estrogen-induced cardiorenal protection: potential cellular, biochemical, and molecular mechanisms
    Dubey, RK
    Jackson, EK
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2001, 280 (03) : F365 - F388
  • [8] Cardiovascular pharmacology of estradiol metabolites
    Dubey, RK
    Tofovic, SP
    Jackson, EK
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 308 (02) : 403 - 409
  • [9] Estradiol metabolites inhibit endothelin synthesis by an estrogen receptor-independent mechanism
    Dubey, RK
    Jackson, EK
    Keller, PJ
    Imthurn, B
    Rosselli, M
    [J]. HYPERTENSION, 2001, 37 (02) : 640 - 644
  • [10] Loss of atheroprotective effect of estradiol in immunodeficient mice.
    Elhage, R
    Clamens, S
    Reardon-Alulis, C
    Getz, GS
    Fievet, C
    Maret, A
    Arnal, JF
    Bayard, F
    [J]. ENDOCRINOLOGY, 2000, 141 (01) : 462 - 465
123